Literature DB >> 20304253

Critical analysis of deaths due to atypical pneumonia during the onset of the influenza A (H1N1) virus epidemic.

Israel Grijalva-Otero1, Juan Osvaldo Talavera, Fortino Solorzano-Santos, Guillermo Vazquez-Rosales, Svetlana Vladislavovna-Doubova, Ricardo Pérez-Cuevas, Guadalupe Miranda-Novales, Carmen García-Peña, Claudia Espinel-Bermúdez, Javier Torres, Jorge Escobedo de la Peña.   

Abstract

BACKGROUND: The ongoing influenza A (H1N1) pandemic stroked Mexico and posed a huge challenge to the medical care and public health systems. This report analyzes the clinical course and process of care of patients who died due to atypical pneumonia and fulfilled the clinical criteria of suspected case of novel influenza A (H1N1) virus infection.
METHODS: We conducted a retrospective analysis of a series of 38 patients who died between April 7 and April 28, 2009 at Instituto Mexicano del Seguro Social (IMSS) hospitals due to severe pneumonia and respiratory distress. These cases coincided with the beginning of the outbreak, so patients did not undergo laboratory testing to diagnose influenza. According to IMSS and CDC criteria, post-hoc analysis allowed considering the presumptive diagnosis of S-OIV infection. A multidisciplinary group analyzed the information from the clinical charts, laboratory tests, radiographic studies and death certificates, using descriptive statistics.
RESULTS: Most cases were middle-aged (mean 33 years, range: 4-62 years) and previously healthy; 18.4% had an underlying chronic disease, 23.7% were obese and 7.9% were current smokers. None had received the seasonal influenza vaccine; they had cough (92%), fever (86.8%), and malaise (73.7%). The median time from disease onset to hospital admission was 6 days (range 0-8 days). All were admitted to the intensive care unit with pneumonia and/or respiratory distress. Average time from disease onset to death was 8 days (range 4-18 days).
CONCLUSIONS: An increased number of severe cases of atypical pneumonia in previously healthy adults highlight the importance of the availability of a timely surveillance system able to identify sudden increases in the number of cases or presentation of apparently known diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20304253     DOI: 10.1016/j.arcmed.2009.10.010

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  6 in total

Review 1.  Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.

Authors:  Charles R Beck; Rachel Sokal; Nachiappan Arunachalam; Richard Puleston; Anna Cichowska; Anthony Kessel; Maria Zambon; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

2.  Neuraminidase inhibitor therapy in a military population.

Authors:  Mary P Fairchok; Wei-Ju Chen; John C Arnold; Christina Schofield; Patrick J Danaher; Erin A McDonough; Martin Ottolini; Deepika Mor; Michelande Ridore; Timothy H Burgess; Eugene V Millar
Journal:  J Clin Virol       Date:  2015-03-24       Impact factor: 3.168

3.  Socioeconomic factors influencing hospitalized patients with pneumonia due to influenza A(H1N1)pdm09 in Mexico.

Authors:  Toshie Manabe; Anjarath Lorena Higuera Iglesias; Maria Eugenia Vazquez Manriquez; Eduarda Leticia Martinez Valadez; Leticia Alfaro Ramos; Shinyu Izumi; Jin Takasaki; Koichiro Kudo
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

4.  Pneumonia in patients with novel influenza A (H1N1) virus in Southeastern Turkey.

Authors:  Tacettin Ornek; Funda Demirtaş Yalçın; Selami Ekin; Saban Yalçın; Mücahit Yemişen
Journal:  Wien Klin Wochenschr       Date:  2011-02-16       Impact factor: 1.704

5.  Knowledge, attitudes, practices and emotional reactions among residents of avian influenza (H5N1) hit communities in Vietnam.

Authors:  Toshie Manabe; Thuy Hanh Tran; Manh Lam Doan; Thi Hong Van Do; Thi Phuong Thuy Pham; Thi Thanh Huyen Dinh; Thi Mai Phuong Tran; Hung Minh Dang; Jin Takasaki; Quy Chau Ngo; Quoc Toan Ly; Koichiro Kudo
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

Review 6.  Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.

Authors:  Stella G Muthuri; Puja R Myles; Sudhir Venkatesan; Jo Leonardi-Bee; Jonathan S Nguyen-Van-Tam
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.